Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
The study tested selected synthetic promoters in primary human CD8-positive T cells and characterized an NR4A2-responsive subset in vitro and in tumor-infiltrating engineered T cells in a melanoma xenograft model.	OBSERVATIONAL	Supported	0.8581	1 of 4	143
The study developed synthetic promoters responsive to seven transcription factors identified from T-cell activation programs, with a broad dynamic range of inducibility and basal expression.	OBSERVATIONAL	Supported	0.8581	1 of 4	96